Shanghai Junshi Biosciences Co. Ltd.

09/01/2021 | Press release | Distributed by Public on 09/01/2021 06:25

VOLUNTARY ANNOUNCEMENT - COMPLETION OF ROLLING SUBMISSION OF BIOLOGICS LICENSE APPLICATION OF TORIPALIMAB FOR TREATMENT OF NASOPHARYNGEAL CARCINOMA TO THE FDA

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.